Oxurion postpones its Annual General Meeting

The pharmaceutical company Oxurion NV, listed on Euronext Brussels under the symbol OXUR, has announced the postponement of its Annual General Meeting. Originally scheduled for an earlier date, the meeting is now set for June 1, 2026. This decision is due to administrative reasons, as the company's financial statements were not finalized on time.

Based in Leuven, Belgium, Oxurion specializes in acquiring majority stakes in promising European pharmaceutical contract manufacturers. The company aims to build an integrated network of contract manufacturers serving the healthcare sector.

The press release warns of the risks and uncertainties associated with forward-looking statements and emphasizes that it does not constitute an offer to sell securities. Oxurion also highlights the risks inherent in its investments in digital assets, such as Bitcoin and Ethereum.